Acetylation Is Indispensable for p53 Activation

Cell

Volumn 133, Issue 4, 2008, Pages 612-626

  Tang, Yi ^a   Zhao, Wenhui ^a   Chen, Yue ^b   Zhao, Yingming ^b   Gu, Wei ^a  

^a Columbia University ^*  (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

PROTEINS; SIGNALING

Indexed keywords

PROTEIN P53;

ACETYLATION; APOPTOSIS; ARTICLE; CELL GROWTH; CELL STRESS; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

EID: 43049163953     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2008.03.025     Document Type: Article

References (53)

1. W. An J. Kim R.G. Roeder Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53 Cell 117 2004 735 748
2. O. Aparicio J.V. Geisberg K. Struhl Chromatin Immunoprecipitation for determining the association of proteins with specific genomic sequences in vivo Curr. Protoc. Cell Biol. 17 2004 7.1 7.23
3. N.C. Arva T.R. Gopen K.E. Talbott L.E. Campbell A. Chicas D.E. White G.L. Bond A.J. Levine J. Bargonetti A chromatin-associated and transcriptionally inactive p53-Mdm2 complex occurs in Mdm2 SNP309 homozygous cells J. Biol. Chem. 280 2005 26776 26787
4. M. Ashcroft M.H. Kubbutat K.H. Vousden Regulation of p53 function and stability by phosphorylation Mol. Cell. Biol. 19 1999 1751 1758
5. M. Ashcroft Y. Taya K.H. Vousden Stress signals utilize multiple pathways to stabilize p53 Mol. Cell. Biol. 20 2000 3224 3233
6. N.A. Barlev L. Liu N.H. Chehab K. Mansfield K.G. Harris T.D. Halazonetis S.L. Berger Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases Mol. Cell 8 2001 1243 1254
7. S.L. Berger The complex language of chromatin regulation during transcript Nature 447 2007 407 412
8. K. Berns E.M. Hijmans J. Mullenders T.R. Brummelkamp A. Velds M. Heimerikx R.M. Kerkhoven M. Madiredjo W. Nijkamp B. Weigelt A large-scale RNAi screen in human cells identifies new components of the p53 pathway Nature 428 2004 431 437
9. C. Blattner E. Tobiasch M. Litfen H.J. Rahmsdorf P. Herrlich DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation Oncogene 18 1999 1723 1732
10. C.L. Brooks W. Gu Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation Curr. Opin. Cell Biol. 15 2003 164 171
11. C.L. Brooks W. Gu p53 ubiquitination: Mdm2 and beyond Mol. Cell 21 2006 307 315
12. D. Chen N. Kon M. Li W. Zhang J. Qin W. Gu ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor Cell 121 2005 1071 1083
13. S. Das L. Raj B. Zhao A. Bernstein S.A. Aaronson S.W. Lee Hzf determines cell survival upon genotoxic stress by modulating p53 transactivation Cell 130 2007 624 637
14. D. Dornan I. Wertz H. Shimizu D. Arnott G.D. Frantz P. Dowd K. O'Rourke H. Koeppen V.M. Dixit The ubiquitin ligase COP1 is a critical negative regulator of p53 Nature 429 2004 86 92
15. N. Dumaz D.W. Meek Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2 EMBO J. 18 1999 7002 7010
16. W.S. el-Deiry T. Tokino V.E. Velculescu D.B. Levy R. Parsons J.M. Trent D. Lin W.E. Mercer K.W. Kinzler B. Vogelstein WAF1, a potential mediator of p53 tumor suppression Cell 75 1993 817 825
17. J.M. Espinosa B.M. Emerson Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment Mol. Cell 8 2001 57 69
18. L. Feng T. Lin H. Uranishi W. Gu Y. Xu Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity Mol. Cell. Biol. 25 2005 5389 5395
19. W. Gu R.G. Roeder Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain Cell 90 1997 595 606
20. A. Ito C.H. Lai X. Zhao S. Saito M.H. Hamilton E. Appella T.P. Yao p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2 EMBO J. 20 2001 1331 1340
21. T. Jenuwein C.D. Allis Translating the histone code Science 293 2001 1074 1080
22. S.N. Jones A.E. Roe L.A. Donehower A. Bradley Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53 Nature 378 1995 206 208
23. W.S. Joo P.D. Jeffrey S.B. Cantor M.S. Finnin D.M. Livingston N.P. Pavletich Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure Genes Dev. 16 2002 583 593
24. J.E. Kim J. Chen Z. Lou DBC1 is a negative regulator of SIRT1 Nature 451 2008 583 586
25. C.D. Knights J. Catania S. Di Giovanni S. Muratoglu R. Perez A. Swartzbeck A.A. Quong X. Zhang T. Beerman R.G. Pestell M.L. Avantaggiati Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate J. Cell Biol. 173 2006 533 544
26. K.A. Krummel C.J. Lee F. Toledo G.M. Wahl The C-terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivation Proc. Natl. Acad. Sci. USA 102 2005 10188 10193
27. R. Kulikov M. Winter C. Blattner Binding of p53 to the central domain of Mdm2 is regulated by phosphorylation J. Biol. Chem. 281 2006 28575 28583
28. R.P. Leng Y. Lin W. Ma H. Wu B. Lemmers S. Chung J.M. Parant G. Lozano R. Hakem S. Benchimol Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation Cell 112 2003 779 791
29. A.G. Li L.G. Piluso X. Cai B.J. Gadd A.G. Ladurner X. Liu An acetylation switch in p53 mediates holo-TFIID recruitment Mol. Cell 28 2007 408 421
30. J. Luo F. Su D. Chen A. Shiloh W. Gu Deacetylation of p53 modulates its effect on cell growth and apoptosis Nature 408 2000 377 381
31. J. Luo A.Y. Nikolaev S. Imai D. Chen F. Su A. Shiloh L. Guarente W. Gu Negative control of p53 by Sir2alpha promotes cell survival under stress Cell 107 2001 137 148
32. J. Luo M. Li Y. Tang M. Laszkowska R.G. Roeder W. Gu Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo Proc. Natl. Acad. Sci. USA 101 2004 2259 2264
33. J.C. Marine A.G. Jochemsen Mdmx as an essential regulator of p53 activity Biochem. Biophys. Res. Commun. 331 2005 750 760
34. D. Michael M. Oren The p53-Mdm2 module and the ubiquitin system Semin. Cancer Biol. 13 2003 49 58
35. N. Minsky M. Oren The RING domain of Mdm2 mediates histone ubiquitylation and transcriptional repression Mol. Cell 16 2004 631 639
36. R. Montes de Oca Luna D.S. Wagner G. Lozano Rescue of early embryonic lethality in Mdm2-deficient mice by deletion of p53 Nature 378 1995 203 206
37. S. Ohkubo T. Tanaka Y. Taya K. Kitazato C. Prives Excess HDM2 impacts cell cycle and apoptosis and has a selective effect on p53-dependent transcription J. Biol. Chem. 281 2006 16943 16950
38. C. Prives P.A. Hall The p53 pathway J. Pathol. 187 1999 112 126
39. I. Ringshausen C.C. O'Shea A.J. Finch L.B. Swigart G.I. Evan Mdm2 is critically and continuously required to suppress lethal p53 activity in vivo Cancer Cell 10 2006 501 514
40. A. Sullivan X. Lu ASPP: a new family of oncogenes and tumour suppressor genes Br. J. Cancer 96 2007 196 200
41. S.M. Sykes H.S. Mellert M.A. Holbert K. Li R. Marmorstein W.S. Lane S.B. McMahon Acetylation of the p53 DNA-binding domain regulates apoptosis induction Mol. Cell 24 2006 841 851
42. T. Tanaka S. Ohkubo I. Tatsuno C. Prives hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes Cell 130 2007 638 650
43. Y. Tang J. Luo W. Zhang W. Gu Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis Mol. Cell 24 2006 827 839
44. T. Thompson C. Tovar H. Yang D. Carvajal B.T. Vu Q. Xu G.M. Wahl D.C. Heimbrook L.T. Vassilev Phosphorylation of p53 on key serines is dispensable for transcriptional activation and apoptosis J. Biol. Chem. 279 2004 53015 53022
45. C. Tovar J. Rosinski Z. Filipovic B. Higgins K. Kolinsky H. Hilton X. Zhao B.T. Vu W. Qing K. Packman Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy Proc. Natl. Acad. Sci. USA 103 2006 1888 1893
46. L.T. Vassilev MDM2 inhibitors for cancer therapy Trends Mol. Med. 13 2007 23 31
47. H. Vaziri S.K. Dessain E. Ng Eaton S.I. Imai R.A. Frye T.K. Pandita L. Guarente R.A. Weinberg hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase Cell 107 2001 149 159
48. B. Vogelstein D. Lane A.J. Levine Surfing the p53 network Nature 408 2000 307 310
49. K.H. Vousden D.P. Lane p53 in health and disease Nat. Rev. Mol. Cell Biol. 8 2007 275 283
50. Z. Wu J. Earle S. Saito C.W. Anderson E. Appella Y. Xu Mutation of mouse p53 Ser23 and the response to DNA damage Mol. Cell. Biol. 22 2002 2441 2449
51. G.W. Yu S. Rudiger D. Veprintsev S. Freund M.R. Fernandez-Fernandez A.R. Fersht The central region of HDM2 provides a second binding site for p53 Proc. Natl. Acad. Sci. USA 103 2006 1227 1232
52. W. Zhao J.P. Kruse Y. Tang S.Y. Jung J. Qin W. Gu Negative regulation of the deacetylase SIRT1 by DBC1 Nature 451 2008 587 590
53. A. Zupnick C. Prives Mutational analysis of the p53 core domain L1 loop J. Biol. Chem. 281 2006 20464 20473